208 related articles for article (PubMed ID: 14576140)
21. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
22. [Azole resistance in Candida spp].
Kakeya H; Miyazaki T; Miyazaki Y; Kohno S
Nihon Ishinkin Gakkai Zasshi; 2003; 44(2):87-92. PubMed ID: 12748589
[TBL] [Abstract][Full Text] [Related]
23. A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Watanabe K; Kadota JI
Med Mycol J; 2017; 58(1):E23-E28. PubMed ID: 28250360
[TBL] [Abstract][Full Text] [Related]
24. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y
J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
[TBL] [Abstract][Full Text] [Related]
25. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
Morio F; Loge C; Besse B; Hennequin C; Le Pape P
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):373-84. PubMed ID: 20226328
[TBL] [Abstract][Full Text] [Related]
26. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
27. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
28. First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis.
Kano R; Okubo M; Yanai T; Hasegawa A; Kamata H
Mycopathologia; 2015 Dec; 180(5-6):427-33. PubMed ID: 26162642
[TBL] [Abstract][Full Text] [Related]
29. Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.
Gast CE; Basso LR; Bruzual I; Wong B
Antimicrob Agents Chemother; 2013 Nov; 57(11):5478-85. PubMed ID: 23979758
[TBL] [Abstract][Full Text] [Related]
30. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
Feng LJ; Wan Z; Wang XH; Li RY; Liu W
Chin Med J (Engl); 2010 Mar; 123(5):544-8. PubMed ID: 20367978
[TBL] [Abstract][Full Text] [Related]
31. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.
Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H
Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192
[TBL] [Abstract][Full Text] [Related]
32.
Nobrega de Almeida J; Jimenez-Ortigosa C; Francisco EC; Colombo AL; Perlin DS
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0110122. PubMed ID: 36374073
[TBL] [Abstract][Full Text] [Related]
33. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans.
White TC
Antimicrob Agents Chemother; 1997 Jul; 41(7):1488-94. PubMed ID: 9210671
[TBL] [Abstract][Full Text] [Related]
34. Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS.
Alves SH; Lopes JO; Costa JM; Klock C
Rev Inst Med Trop Sao Paulo; 1997; 39(6):359-61. PubMed ID: 9674289
[No Abstract] [Full Text] [Related]
35. Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient.
Kammalac Ngouana T; Drakulovski P; Krasteva D; Kouanfack C; Reynes J; Delaporte E; Boyom FF; Mallié M; Bertout S
J Med Microbiol; 2016 Jul; 65(7):579-589. PubMed ID: 27100672
[TBL] [Abstract][Full Text] [Related]
36. Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient.
Maebashi K; Kudoh M; Nishiyama Y; Makimura K; Kamai Y; Uchida K; Yamaguchi H
Microbiol Immunol; 2003; 47(2):117-24. PubMed ID: 12680714
[TBL] [Abstract][Full Text] [Related]
37. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.
Lockhart SR; Fothergill AW; Iqbal N; Bolden CB; Grossman NT; Garvey EP; Brand SR; Hoekstra WJ; Schotzinger RJ; Ottinger E; Patterson TF; Wiederhold NP
Antimicrob Agents Chemother; 2016 Apr; 60(4):2528-31. PubMed ID: 26787697
[TBL] [Abstract][Full Text] [Related]
38. A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts.
Accoceberry I; Rougeron A; Biteau N; Chevrel P; Fitton-Ouhabi V; Noël T
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038279
[TBL] [Abstract][Full Text] [Related]
39. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
Wu Y; Gao N; Li C; Gao J; Ying C
FEMS Yeast Res; 2017 May; 17(3):. PubMed ID: 28334124
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
Morales IJ; Vohra PK; Puri V; Kottom TJ; Limper AH; Thomas CF
Am J Respir Cell Mol Biol; 2003 Aug; 29(2):232-8. PubMed ID: 12606318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
